ATE469119T1 - Verfahren zur herstellung von polymorphen von sertralin hydrochlorid - Google Patents
Verfahren zur herstellung von polymorphen von sertralin hydrochloridInfo
- Publication number
- ATE469119T1 ATE469119T1 AT04798397T AT04798397T ATE469119T1 AT E469119 T1 ATE469119 T1 AT E469119T1 AT 04798397 T AT04798397 T AT 04798397T AT 04798397 T AT04798397 T AT 04798397T AT E469119 T1 ATE469119 T1 AT E469119T1
- Authority
- AT
- Austria
- Prior art keywords
- polymorphoes
- producing
- sertraline hydrochloride
- sertraline
- hydrochloride
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
- C07C209/82—Purification; Separation; Stabilisation; Use of additives
- C07C209/84—Purification
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C211/39—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton
- C07C211/41—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems
- C07C211/42—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems with six-membered aromatic rings being part of the condensed ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1158MU2003 | 2003-11-04 | ||
| PCT/GB2004/004672 WO2005047229A2 (en) | 2003-11-04 | 2004-11-04 | Process for the preparation of polymorphs of selective serotonin reuptake inhibitor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE469119T1 true ATE469119T1 (de) | 2010-06-15 |
Family
ID=34586963
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04798397T ATE469119T1 (de) | 2003-11-04 | 2004-11-04 | Verfahren zur herstellung von polymorphen von sertralin hydrochlorid |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US7893300B2 (de) |
| EP (1) | EP1682483B1 (de) |
| JP (1) | JP4791970B2 (de) |
| KR (1) | KR101161813B1 (de) |
| CN (1) | CN1902157A (de) |
| AT (1) | ATE469119T1 (de) |
| AU (1) | AU2004289512A1 (de) |
| CA (1) | CA2544684A1 (de) |
| DE (1) | DE602004027401D1 (de) |
| NZ (1) | NZ546902A (de) |
| RU (1) | RU2376279C2 (de) |
| WO (1) | WO2005047229A2 (de) |
| ZA (1) | ZA200603502B (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102235225B1 (ko) * | 2013-06-04 | 2021-06-03 | 더 다우 케미칼 캄파니 | 리튬 카복시메틸 셀룰로오스를 제조하는 방법 |
| CN112552188B (zh) * | 2020-12-17 | 2023-07-28 | 山西仟源医药集团股份有限公司 | 盐酸舍曲林晶型i的制备方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4536518A (en) * | 1979-11-01 | 1985-08-20 | Pfizer Inc. | Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine |
| US5248699A (en) * | 1992-08-13 | 1993-09-28 | Pfizer Inc. | Sertraline polymorph |
| US5734083A (en) * | 1996-05-17 | 1998-03-31 | Torcan Chemical Ltd. | Sertraline polymorph |
| WO1999001121A1 (en) * | 1997-07-01 | 1999-01-14 | Pfizer Inc. | Sertraline salts and sustained-release dosage forms of sertraline |
| US6500987B1 (en) * | 1998-11-27 | 2002-12-31 | Teva Pharmaceutical Industries Ltd. | Sertraline hydrochloride polymorphs |
| US6495721B1 (en) * | 1999-08-09 | 2002-12-17 | Teva Pharmaceutical Industries Ltd. | Sertraline hydrochloride Form II and methods for the preparation thereof |
| TWI260315B (en) | 1999-10-29 | 2006-08-21 | Ciba Sc Holding Ag | Polymorphic forms of sertraline hydrochloride |
| CN1434708A (zh) * | 1999-12-21 | 2003-08-06 | 特瓦制药工业有限公司 | 新的盐酸舍曲林多晶型物、其制备方法、含有它们的组合物和应用它们的方法 |
| AU2003251290A1 (en) | 2002-04-29 | 2003-11-17 | Teva Pharmaceutical Industries Ltd. | Process for preparation of polymorphic form ii of sertraline hydrochloride, pharmaceutical formulations and methods of administration thereof |
-
2004
- 2004-11-04 KR KR1020067010735A patent/KR101161813B1/ko not_active IP Right Cessation
- 2004-11-04 DE DE602004027401T patent/DE602004027401D1/de active Active
- 2004-11-04 RU RU2006119477/04A patent/RU2376279C2/ru not_active IP Right Cessation
- 2004-11-04 US US10/577,714 patent/US7893300B2/en not_active Expired - Fee Related
- 2004-11-04 CN CNA2004800397985A patent/CN1902157A/zh active Pending
- 2004-11-04 AT AT04798397T patent/ATE469119T1/de not_active IP Right Cessation
- 2004-11-04 WO PCT/GB2004/004672 patent/WO2005047229A2/en active Application Filing
- 2004-11-04 NZ NZ546902A patent/NZ546902A/en not_active IP Right Cessation
- 2004-11-04 CA CA002544684A patent/CA2544684A1/en not_active Abandoned
- 2004-11-04 JP JP2006537441A patent/JP4791970B2/ja not_active Expired - Fee Related
- 2004-11-04 ZA ZA200603502A patent/ZA200603502B/en unknown
- 2004-11-04 AU AU2004289512A patent/AU2004289512A1/en not_active Abandoned
- 2004-11-04 EP EP04798397A patent/EP1682483B1/de not_active Not-in-force
Also Published As
| Publication number | Publication date |
|---|---|
| NZ546902A (en) | 2010-02-26 |
| US20070135524A1 (en) | 2007-06-14 |
| WO2005047229A2 (en) | 2005-05-26 |
| AU2004289512A2 (en) | 2005-05-26 |
| WO2005047229A3 (en) | 2005-07-07 |
| CA2544684A1 (en) | 2005-05-26 |
| AU2004289512A1 (en) | 2005-05-26 |
| RU2006119477A (ru) | 2007-12-20 |
| KR20060123234A (ko) | 2006-12-01 |
| JP4791970B2 (ja) | 2011-10-12 |
| DE602004027401D1 (de) | 2010-07-08 |
| EP1682483B1 (de) | 2010-05-26 |
| US7893300B2 (en) | 2011-02-22 |
| KR101161813B1 (ko) | 2012-07-05 |
| RU2376279C2 (ru) | 2009-12-20 |
| EP1682483A2 (de) | 2006-07-26 |
| ZA200603502B (en) | 2008-02-27 |
| JP2007510640A (ja) | 2007-04-26 |
| CN1902157A (zh) | 2007-01-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE425136T1 (de) | Verfahren zur herstellung substituierter 3-aryl- butyl-aminverbindungen | |
| ATE529409T1 (de) | Verfahren zur herstellung von kristallinen aripiprazolformen | |
| DE602004031895D1 (de) | Verfahren zur Herstellung von Dichlorpropanol | |
| DE60323192D1 (de) | Verfahren zur Herstellung von Hydroxyalkylstärkederivaten | |
| DE602004010234D1 (de) | Verfahren zur herstellung von 4-aminodiphenylamin | |
| ATE501264T1 (de) | Enzymatische verfahren zur herstellung 4- substituierter 3-hydroxybuttersäure-derivate | |
| ATE444950T1 (de) | Verfahren zur herstellung von 1-amino-3,5- dimethyladamantan-hydrochlorid | |
| ATE354583T1 (de) | Verfahren zur herstellung c-7 substituierter 5- androstene | |
| DE50311721D1 (de) | Verfahren zur Herstellung von Aryl-aminopropanolen | |
| ATE424892T1 (de) | Verfahren zur herstellung von derivaten des 4a,5, 9,10,11,12-hexahydrobenzofuro ä3a,3,2üä 2 ü- benzazepins | |
| DE60210778D1 (de) | Verfahren zur herstellung von 4-amino-2,5-bisheterocyclylchinazolinen | |
| DE60322356D1 (de) | Verfahren zur herstellung von 2-aminoindanderivaten | |
| DE60335766D1 (de) | Verfahren zur Herstellung von m-Xylylendiamin | |
| DE60309847D1 (de) | Zwischenprodukte und verfahren zur herstellung von heptapeptid-oxytocinanaloga | |
| ATE469119T1 (de) | Verfahren zur herstellung von polymorphen von sertralin hydrochlorid | |
| ATE325794T1 (de) | Verfahren zur herstellung und zwischenprodukte von pyridin-2-yl-amin | |
| DE50211253D1 (de) | Verfahren zur Herstellung von Makrokapseln | |
| DE602004027840D1 (de) | Verfahren zur herstellung von thiazolopyrimidinen | |
| DE602004005239D1 (de) | Verfahren zur herstellung von tubulininhibitoren | |
| ATE496038T1 (de) | Verfahren zur herstellung von quetiapin | |
| DE60301444T2 (de) | Verfahren zur Herstellung von Polyalkylphenoxyaminoalkanen | |
| DE602004018447D1 (de) | Verfahren zur Herstellung von Alkylbenzaldehyden | |
| DE60302979D1 (de) | Verfahren zur Herstellung von Epsilon-Caprolactone | |
| DE502004011536D1 (de) | verfahren zur herstellung von bengamide-derivaten | |
| DE60330749D1 (de) | Verfahren zur herstellung von 7-alpha-methylsteroide |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |